Dr. Julia Strasser
Being a member of our renowned Life Sciences Industry Team, Julia advises national as well as international innovative clients in the pharmaceutical, medical devices and biotech industry. She focuses on regulatory and commercial matters. Julia assists in every stage of the product life-cycle, from early and clinical development to the divestment of life sciences products including pricing and reimbursement. In particular, Julia handles questions concerning patient access to pharmaceuticals prior to marketing authorization and regulatory challenges regarding the inclusion of digital technologies into product portfolio and clinical trials. Additionally, she is also specialized in issues relating to business compliance and anti-corruption.
Julia studied law at the University of Passau and at Capital University Law School in Columbus/Ohio. As a fellow at New York University Law School and academic assistant to the Chair of (International) Employment Law, Comparative Employment Law and Civil Law at the University in Munich, she obtained her PhD. During her legal trainee-ship, Julia worked for international and domestic law firms in the area of employment and medical law in Munich and Vienna.
Areas of Focus
Advising a leading pharmaceutical company regarding the sale of digital technologies in commercial product offerings and inclusion in clinical trials.
Conducting an internal legal and compliance review for a worldwide leading pharmaceutical company in regard to early access programs.
Advising on the setting up of a new compliance system for a German company in regard to collaborations with healthcare professional.
Legal review of marketing materials and claims based on diverse clinical studies for an international medical devices company.
Advising a German company on commercial and advertising strategies for the launch of an application system for analgesics.
Advising an U.S.- based biopharmaceutical company on pricing and reimbursement regulations and strategies specific to Germany.
Advice to U.S.-based pharmaceutical company on early access, distribution and pricing issues, reimbursement and compliance.